Advanced diagnostic and prognostic solutions for urological cancer care 

No matter which test(s) you receive from our growing portfolio of traditional and breakthrough products and services, rest assured they are backed by our superior clinical expertise and the
highest level of customer support.

Press Release

Metamark Announces Nationwide Availability of ProMark™ Prostate Cancer Test, First-of-its-Kind Protein-Based Prognostic Test

Metamark announced today the nationwide availability of ProMark™, the first-of-its-kind protein-based biopsy test designed to improve the accuracy of prognosis for men diagnosed with prostate cancer.

read article
Press Release

METAMARK GENETICS INITIATES CLINICAL USE OF ProMark™

Metamark Genetics, Inc. today announced that it has initiated clinical use of the company’s ProMark™ prognostic test to help guide the medical management of patients with early-stage prostate cancer.

read article
Displaying results 9-10 (of 13)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7  >  >|